Pluri Inc. — Director's Dealing 2018

Dec 20, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2018-12-19

Reporting Person: Egozi Erez (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-19	Common Stock	A	80000	—	Acquired	468000	Direct
2018-12-19	Common Stock	A	50000	—	Acquired	518000	Direct
2018-12-19	Common Stock	A	30000	—	Acquired	548000	Direct

Footnotes

F1: The shares vest as follows: 25% shall vest on the 6 month anniversary of the date of grant and the remaining shares vest in 6 equal installments every 3 months thereafter.

F2: The shares vest as follows: 12.5% on the 27 month anniversary of the date of grant and the remaining shares vest in 7 equal installments every 3 months thereafter.

F3: The shares vest upon achievement of certain operational and financial goals.